𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.2.033 Paroxetine augmentation of neuroleptic treatment in chronic schizophrenia: An open label pilot study

✍ Scribed by M.C. Jockers-Scherübl; F. Godemann; A. Pietzcker


Book ID
118599956
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
143 KB
Volume
7
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Duloxetine in the treatment of irritable
✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal